|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamashita T and Kaneko S: Liver cancer.
Rinsho byori. 64:787–796. 2016.In Japanese. PubMed/NCBI
|
|
4
|
Lu X, Sun W, Tang Y, Zhu L, Li Y, Ou C,
Yang C, Su J, Luo C, Hu Y and Cao J: Identification of key genes in
hepatocellular carcinoma and validation of the candidate gene,
cdc25a, using gene set enrichment analysis, meta-analysis and
cross-species comparison. Mol Med Rep. 13:1172–1178. 2016.
View Article : Google Scholar :
|
|
5
|
Shen T and Huang S: The role of Cdc25A in
the regulation of cell proliferation and apoptosis. Anticancer
Agents Med Chem. 12:631–639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harbour JW, Luo RX, Dei Santi A, Postigo
AA and Dean DC: Cdk phosphorylation triggers sequential
intramolecular interactions that progressively block Rb functions
as cells move through G1. Cell. 98:859–869. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sur S and Agrawal DK: Phosphatases and
kinases regulating CDC25 activity in the cell cycle: Clinical
implications of CDC25 overexpression and potential treatment
strategies. Mol Cell Biochem. 416:1–14. 2016. View Article : Google Scholar
|
|
8
|
Li H, Jiang M, Cui M, Feng G, Dong J, Li
Y, Xiao H and Fan S: MiR-365 enhances the radiosensitivity of
non-small cell lung cancer cells through targeting CDC25A. Biochem
Biophys Res Commun. 512:392–398. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin H and Liu W: MicroRNA-99a-5p
suppresses breast cancer progression and cell-cycle pathway through
downregulating CDC25A. J Cell Physiol. 234:3526–3537. 2019.
View Article : Google Scholar
|
|
10
|
Luo A, Zhou X, Shi X, Zhao Y, Men Y, Chang
X, Chen H, Ding F, Li Y, Su D, et al: Exosome-derived miR-339-5p
mediates radio-sensitivity by targeting Cdc25A in locally advanced
esophageal squamous cell carcinoma. Oncogene. 38:4990–5006. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ataie-Kachoie P, Pourgholami MH,
Richardson DR and Morris DL: Gene of the month: Interleukin 6
(IL-6). J Clin Pathol. 67:932–937. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sato Y, Goto Y, Narita N and Hoon DS:
Cancer cells expressing toll-like receptors and the tumor
microenvironment. Cancer Microenviron. 2(Suppl 1): S205–S214. 2009.
View Article : Google Scholar
|
|
13
|
Yuan FJ, Zhou YS, Wei Y, Zou C, Chen L,
Huang L and Liu Z: Increased expression of IL-6 mRNA in
hepatocellular carcinoma cell lines correlates with biological
characteristics. Asian Pac J Cancer Prev. 12:3361–3365.
2011.PubMed/NCBI
|
|
14
|
Schmidt-Arras D and Rose-John S: IL-6
pathway in the liver: From physiopathology to therapy. J Hepatol.
64:1403–1415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou M, Yang H, Learned RM, Tian H and
Ling L: Non-cell-autonomous activation of IL-6/STAT3 signaling
mediates FGF19-driven hepatocarcinogenesis. Nat Commun.
8:154332017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rayet B and Gelinas C: Aberrant rel/nfkb
genes and activity in human cancer. Oncogene. 18:6938–6947. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin L and Yu X: Arsenic-induced apoptosis
in the p53-proficient and p53-deficient cells through differential
modulation of NFkB pathway. Food Chem Toxicol. 118:849–860. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sheng ML, Xu GL, Zhang CH, Jia WD, Ren WH,
Liu WB, Zhou T, Wang YC, Lu ZL, Liu WF, et al: Aberrant estrogen
receptor alpha expression correlates with hepatocellular carcinoma
metastasis and its mechanisms. Hepatogastroenterology. 61:146–150.
2014.PubMed/NCBI
|
|
19
|
Xu H, Wei Y, Zhang Y, Xu Y, Li F, Liu J,
Zhang W, Han X, Tan R and Shen P: Oestrogen attenuates tumour
progression in hepatocellular carcinoma. J Pathol. 228:216–229.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
21
|
Hong HY, Choi J, Cho YW and Kim BC: Cdc25A
promotes cell survival by stimulating NF-κB activity through IκB-α
phosphorylation and destabilization. Biochem Biophys Res Commun.
420:293–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He P: Screening of differentially
expressed genes in liver cancer HepG2 cells after silencing CDC25A
gene. Guangxi Med Univ. 2018.
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Källström H, Lindqvist A, Pospisil V,
Lundgren A and Rosenthal CK: Cdc25A localisation and shuttling:
Characterisation of sequences mediating nuclear export and import.
Exp Cell Res. 303:89–100. 2005. View Article : Google Scholar
|
|
25
|
Dozier C, Mazzolini L, Cénac C, Froment C,
Burlet-Schiltz O, Besson A and Manenti S: CyclinD-CDK4/6 complexes
phosphorylate CDC25A and regulate its stability. Oncogene.
36:3781–3788. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Kar S and Carr BI: Cdc25A protein
phosphatase: A therapeutic target for liver cancer therapies.
Anticancer Agents Med Chem. 8:863–871. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou X, Tsutsui T, Ray D, Blomquist JF,
Ichijo H, Ucker DS and Kiyokawa H: The cell cycle-regulatory CDC25A
phosphatase inhibits apoptosis signal-regulating kinase 1. Mol Cell
Biol. 21:4818–4828. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang J, Cao R, Zhang Y, Xia Y, Zheng Y,
Li X, Wang L, Yang W and Lu Z: PKM2 dephosphorylation by Cdc25A
promotes the Warburg effect and tumorigenesis. Nat Commun.
7:124312016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feng X, Wu Z, Wu Y, Hankey W, Prior TW, Li
L, Ganju RK, Shen R and Zou X: Cdc25A regulates matrix
metalloprotease 1 through Foxo1 and mediates metastasis of breast
cancer cells. Mol Cell Biol. 31:3457–3471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang XQ, Zhu YQ, Lui KS, Cai Q, Lu P and
Poon RT: Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic
hepatocellular carcinoma. Clin Cancer Res. 14:6813–6820. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu X, Yamamoto H, Sakon M, Yasui M, Ngan
CY, Fukunaga H, Morita T, Ogawa M, Nagano H, Nakamori S, et al:
Overexpression of CDC25A phosphatase is associated with hypergrowth
activity and poor prognosis of human hepatocellular carcinomas.
Clin Cancer Res. 9:1764–1772. 2003.PubMed/NCBI
|
|
32
|
Xu X, Yamamoto H, Liu G, Ito Y, Ngan CY,
Kondo M, Nagano H, Dono K, Sekimoto M and Monden M: CDC25A
inhibition suppresses the growth and invasion of human
hepatocellular carcinoma cells. Int J Mol Med. 21:145–152.
2008.PubMed/NCBI
|
|
33
|
Fu S and Lin J: Blocking interleukin-6 and
interleukin-8 signaling inhibits cell viability, colony-forming
activity, and cell migration in human triple-negative breast cancer
and pancreatic cancer cells. Anticancer Res. 38:6271–6279. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang Q, Zhang Z, Liao Y, Liu C, Fan S,
Wei X, Ai B and Xiong J: 17β-estradiol upregulates IL6 expression
through the ERβ pathway to promote lung adenocarcinoma progression.
J Exp Clin Cancer Res. 37:1332018. View Article : Google Scholar
|
|
35
|
Wang Y, Zong X, Mitra S, Mitra AK, Matei D
and Nephew KP: IL-6 mediates platinum-induced enrichment of ovarian
cancer stem cells. JCI Insight. 3:pii: 122360. 2018. View Article : Google Scholar
|
|
36
|
Yin Z, Ma T, Lin Y, Lu X, Zhang C, Chen S
and Jian Z: IL-6/STAT3 pathway intermediates M1/M2 macrophage
polarization during the development of hepatocellular carcinoma. J
Cell Biochem. 119:9419–9432. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bournazou E and Bromberg J: Targeting the
tumor microenvironment: JAK-STAT3 signaling. JAKSTAT.
2:e238282013.PubMed/NCBI
|
|
38
|
Rokavec M, Wu W and Luo JL: IL6-mediated
suppression of miR-200c directs constitutive activation of
inflammatory signaling circuit driving transformation and
tumorigenesis. Mol Cell. 45:777–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Al Zaid Siddiquee K and Turkson J: STAT3
as a target for inducing apoptosis in solid and hematological
tumors. Cell Res. 18:254–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Subramaniam A, Shanmugam MK, Ong TH, Li F,
Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, et al:
Emodin inhibits growth and induces apoptosis in an orthotopic
hepato-cellular carcinoma model by blocking activation of STAT3. Br
J Pharmacol. 170:807–821. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C,
Huo S, Duan J, Tao J, Zhai M, et al: Bazedoxifene exhibits growth
suppressive activity by targeting interleukin-6/glycoprotein
130/signal transducer and activator of transcription 3 signaling in
hepatocellular carcinoma. Cancer Sci. 110:950–961. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiang M, Birkbak NJ, Vafaizadeh V, Walker
SR, Yeh JE, Liu S, Kroll Y, Boldin M, Taganov K, Groner B, et al:
STAT3 induction of miR-146b forms a feedback loop to inhibit the
NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.
Sci Signal. 7:ra112014. View Article : Google Scholar
|
|
43
|
Duan XH, Li H, Han XW, Ren JZ, Li FY, Ju
SG, Chen PF and Kuang DL: Upregulation of IL-6 is involved in
moderate hyperthermia induced proliferation and invasion of
hepatocellular carcinoma cells. Eur J Pharmacol. 833:230–236. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Korkaya H, Liu S and Wicha MS: Regulation
of cancer stem cells by cytokine networks: Attacking cancer's
inflammatory roots. Clin Cancer Res. 17:6125–6129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stylianou E and Saklatvala J:
Interleukin-1. Int J Biochem Cell Biol. 30:1075–1079. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu R, Chen B, Jia X, Qiu Y, Liu M, Huang
C, Feng J and Wu Q: Interleukin-1β influences functional
regeneration following nerve injury in mice through nuclear
factor-κB signaling pathway. Immunology. 156:235–248. 2019.
View Article : Google Scholar
|
|
47
|
Sun K, Xu L, Jing Y, Jing Y, Han Z, Chen
X, Cai C, Zhao P, Zhao X and Yang L: Autophagy-deficient Kupffer
cells promote tumorigenesis by enhancing
mtROS-NF-κB-IL1α/β-dependent inflammation and fibrosis during the
preneoplastic stage of hepatocarcinogenesis. Cancer Lett.
388:198–207. 2017. View Article : Google Scholar
|
|
48
|
Nomura A, Gupta VK, Dauer P, Sharma NS,
Dudeja V, Merchant N, Saluja AK and Banerjee S: NFκB-mediated
inva-siveness in CD133+ pancreatic TICs is regulated by autocrine
and paracrine activation of IL1 signaling. Mol Cancer Res.
16:162–172. 2018. View Article : Google Scholar
|
|
49
|
Voronov E, Shouval DS, Krelin Y, Cagnano
E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is
required for tumor invasiveness and angiogenesis. Proc Natl Acad
Sci USA. 100:2645–2650. 2003. View Article : Google Scholar : PubMed/NCBI
|
